FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090367 [Registered on: 07/07/2025] Trial Registered Prospectively
Last Modified On: 04/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of effectiveness of pre operative and post operative Lornoxicam in surgical removal of mandibular third molar  
Scientific Title of Study   Comparison of efficacy of pre-emptive and post operative lornoxicam in mandibular third molar surgeries - A split mouth study.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Bhavana G Ammanagi 
Designation  Post Graduate Research Scholar 
Affiliation  Raja Rajeswari dental college and hospital, Bangalore 
Address  Department of Oral and Maxillofacial surgery Raja Rajeswari dental college and hospital No 14 Ramohalli cross Kumbalagodu Mysore road Bangalore Karnataka India
Department of Oral and Maxillofacial surgery Raja Rajeswari dental college and hospital No 14 Ramohalli cross Kumbalagodu Mysore road Bangalore Karnataka India
Bangalore Rural
KARNATAKA
560074
India 
Phone  9108706071  
Fax    
Email  bhavanaammanagi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Narahari Ranganatha 
Designation  Professor 
Affiliation  Raja Rajeswari dental college and hospital, Bangalore 
Address  Department of Oral and Maxillofacial surgery Raja Rajeswari dental college and hospital No 14 Ramohalli cross Kumbalagodu Mysore road Bangalore Karnataka India
Department of Oral and Maxillofacial surgery Raja Rajeswari dental college and hospital No 14 Ramohalli cross Kumbalagodu Mysore road Bangalore Karnataka India
Bangalore Rural
KARNATAKA
560074
India 
Phone  9342519662  
Fax    
Email  narahari2012@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Bhavana G Ammanagi 
Designation  Post Graduate Research Scholar 
Affiliation  Raja Rajeswari dental college and hospital, Bangalore 
Address  Department of Oral and Maxillofacial surgery Raja Rajeswari dental college and hospital No 14 Ramohalli cross Kumbalagodu Mysore road Bangalore Karnataka India
Department of Oral and Maxillofacial surgery Raja Rajeswari dental college and hospital No 14 Ramohalli cross Kumbalagodu Mysore road Bangalore Karnataka India
Bangalore Rural
KARNATAKA
560074
India 
Phone  9108706071  
Fax    
Email  bhavanaammanagi@gmail.com  
 
Source of Monetary or Material Support  
Department of Oral and Maxillofacial surgery Raja Rajeswari dental college and hospital No 14 Ramohalli cross Kumbalagodu Mysore road Bangalore 560074 Karnataka India  
 
Primary Sponsor  
Name  Dr Bhavana G Ammanagi 
Address  Department of Oral and Maxillofacial surgery Raja Rajeswari dental college and hospital No 14 Ramohalli cross Kumbalagodu Mysore road Bangalore 560074 Karnataka India  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bhavana G Ammanagi  Raja Rajeswari dental college and hospital Bangalore   Department of Oral and Maxillofacial surgery Raja Rajeswari dental college and hospital No 14 Ramohalli cross Kumbalagodu Mysore road Bangalore 560074 Karnataka India
Bangalore Rural
KARNATAKA 
9108706071

bhavanaammanagi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Raja Rajeswari dental college and hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K011||Impacted teeth,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Tablet Lornoxicam 8 mg  Tablet Lornoxicam 8 mg given one hour post operatively. 
Intervention  Tablet Lornoxicam 8 mg  Tablet Lornoxicam 8 mg given one hour pre operatively.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Patients with bilaterally similar impacted mandibular third molars.
2) Patients classified under ASA I and ASA II requiring surgical extraction of bilaterally similar impacted mandibular third molars.
3) Patient willing to sign the informed consent. 
 
ExclusionCriteria 
Details  1) Patients with erupted third molars.
2) Patients classified under ASA III and ASA IV.
3) Patients who have consumed any other analgesics in 24 hours before surgery.
4) Patients with gastritis and peptic ulcers.
5) Pregnant patients.
6) Patients with psychiatric illness.
7) Patients with infections like pericoronitis, pericoronal abscess, etc 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1) The efficacy of Lornoxicam as a pre emptive and post operative analgesic.
2) Post operative pain
3) The number of rescue analgesics taken within 24 hours of the procedure.
4) Patient satisfaction by Likert scale. 
1)The efficacy of Lornoxicam as a pre emptive analgesic.
2)The efficacy of Lornoxicam as a post operative analgesic.
3)Pain at 2nd, 4th, 6th, 12th, and 24th hour post operatively using VAS.
4)The number of rescue analgesics taken within 24 hours of the procedure.
5)The patient satisfaction by Likert scale on 7th follow up day. 
 
Secondary Outcome  
Outcome  TimePoints 
1) The effectiveness of Lornoxicam as a pre emptive analgesic.
2) The effectiveness of Lornoxicam as a post operative analgesic.
3) Post operative pain
4) The number of rescue analgesics taken.
5) Patient satisfaction by Likert scale. 
1)The efficacy of Lornoxicam as a pre emptive analgesic.
2)The efficacy of Lornoxicam as a post operative analgesic.
3)Pain at 2nd, 4th, 6th, 12th, & 24th hour post operatively using VAS.
4)The number of rescue analgesics taken within 24 hours of the procedure.
5)The patient satisfaction by Likert scale on 7th follow up day. 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   14/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   After obtaining approval and clearance from the Institutional Ethical Committee the patients fulfilling the inclusion criteria will be enrolled for the study. Patients requiring surgical removal of impacted third molars on mandibular arch are taken up after radiographical assessment is done. Surgical site will be randomly divided into two groups Group A will receive tablet Lornoxicam eight mg one hour before the surgery and Group B will receive tablet Lornoxicam eight mg one hour after the surgery. Patient will be asked to rinse the oral cavity thoroughly and standard painting and draping of the patient will be done. The procedure will be performed under Local anesthesia two percent lignocaine with adrenaline. Classical inferior alveolar nerve block will be given. Once the anesthesia is achieved surgical assess will be gained. Bone will be removed around the tooth under copious irrigation. The crown and roots will be sectioned if necessary. Third molar will be removed surgically with minimal trauma to investing tissues. Socket toileting will be done followed by primary closure. Antibiotics and Analgesics will be prescribed post operatively. Post operative instructions will be given and is instructed to consume first rescue analgesic tablet Lornoxicam eight mg as soon as the patient experiences pain. The patient will be assessed for pain post operative hours through questionnaire. Patient satisfaction will be recorded using Likert five point scale post operatively 
Close